- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02512224
Comparison of Outcomes Between Parenteral and Enteral Nutrition
September 10, 2015 updated by: Sumito Ogawa, Tokyo University
Comparison of Short-term Mortality and Morbidity Between Parenteral and Enteral Nutrition for Adults Without Cancer: a Propensity-matched Analysis Using a National Inpatient Database
Short-term outcomes of parenteral and enteral nutrition for patients unable to eat normally were compared and analyzed.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Data were acquired from patients selected from a national inpatient database covering 1,057 hospitals in Japan.
Participants had received artificial nutrition between April 2012 and March 2013, were 20 years or older, and did not have cancer.
Participants were grouped into two groups: those receiving parenteral nutrition and those receiving enteral nutrition.
The investigators performed one-to-one propensity-score matching between the groups.
The primary outcome measurements were mortality rates at 30 and 90 days after the start of the procedure.
The secondary outcomes were post-procedural complications, pneumonia, and sepsis.
The investigators analyzed survival length of stay after the procedure using a Cox proportional hazards model.
Study Type
Observational
Enrollment (Actual)
5824
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
For this study, the investigators used the Japanese Diagnosis Procedure Combination database, the details of which have been described elsewhere.
The database includes administrative claims and discharge abstract data.
In 2012, these data were collected for about seven million inpatients from 1,057 participating hospitals across Japan, which amounted to about half of the acute-care hospitalizations in the country.
Description
Inclusion Criteria:
- investigators selected participants aged 20 years or older who had undergone either parenteral nutrition by central venous port insertion or enteral nutrition by percutaneous endoscopic gastrostomy, percutaneous transesophageal gastrotubing, or ileostomy between April 1, 2012, and March 31, 2013. Patients who received both gastrostomy and central venous port insertion were assigned to the gastrostomy group.
Exclusion Criteria:
- investigators excluded participants who had been diagnosed with cancer.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Parenteral nutrition
investigators selected participants aged 20 years or older who had undergoneparenteral nutrition by central venous port insertion between April 1, 2012, and March 31, 2013.
|
Participants are retrospectively selected with propensity score matching
|
Enteral nutrition
investigators selected participants aged 20 years or older who had undergone enteral nutrition by percutaneous endoscopic gastrostomy, percutaneous transesophageal gastrotubing, or ileostomy between April 1, 2012, and March 31, 2013.
|
Participants are retrospectively selected with propensity score matching
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Mortality Calculated From Outcome Section From DPC Database at 90 Days
Time Frame: 90 days after the start of the procedure
|
90 days after the start of the procedure
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Post-procedural Pneumonia
Time Frame: the incidence of post-procedural pneumonia occurring during hospitalization. Participants will be followed for the duration of hospital stay, an expected median of 3 weeks after procedure.
|
the incidence of post-procedural pneumonia occurring during hospitalization. Participants will be followed for the duration of hospital stay, an expected median of 3 weeks after procedure.
|
Post-procedural Sepsis
Time Frame: the incidence of post-procedural sepsis occurring during hospitalization. Participants will be followed for the duration of hospital stay, an expected median of 3 weeks after procedure.
|
the incidence of post-procedural sepsis occurring during hospitalization. Participants will be followed for the duration of hospital stay, an expected median of 3 weeks after procedure.
|
Re-admission 30 Days
Time Frame: re-admission within 30 days of discharge.
|
re-admission within 30 days of discharge.
|
Mortality Calculated From Outcome Section From DPC Database at 14 Days
Time Frame: 14 days after the start of the procedure
|
14 days after the start of the procedure
|
Mortality Calculated From Outcome Section From DPC Database at 30 Days
Time Frame: 30 days after the start of the procedure
|
30 days after the start of the procedure
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Sumito Ogawa, MD. PhD., Tokyo University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2012
Primary Completion (Actual)
March 1, 2013
Study Completion (Actual)
December 1, 2014
Study Registration Dates
First Submitted
July 28, 2015
First Submitted That Met QC Criteria
July 28, 2015
First Posted (Estimate)
July 30, 2015
Study Record Updates
Last Update Posted (Estimate)
September 30, 2015
Last Update Submitted That Met QC Criteria
September 10, 2015
Last Verified
September 1, 2015
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- MHLW H26-Policy-011
- MHLW H26-Special-047 (Other Grant/Funding Number: Ministry of Health, Labour and Welfare, Japan)
- NCGG 25-11 (Other Grant/Funding Number: National Center for Geriatrics and Gerontology , Japan)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Deglutition Disorders
-
Boston Children's HospitalWithdrawnBottle Feeding | Deglutition Disorders in Infants
-
National Institute of Neurological Disorders and...Completed
-
University of NebraskaCompletedDeglutition DisorderUnited States
-
Ulsan University HospitalWithdrawnDeglutition DisorderKorea, Republic of
-
Ulsan University HospitalWithdrawnDeglutition DisorderKorea, Republic of
-
National Institutes of Health Clinical Center (CC)Completed
-
National Institutes of Health Clinical Center (CC)Completed
-
University of ManchesterCompleted
-
Hacettepe UniversityCompletedQuality of Life | Dysphagia | Deglutition Disorder | Outcome AssessmentTurkey
Clinical Trials on Parenteral nutrition
-
Hospital Pediátrico de SinaloaRecruitingCholestasis in NewbornMexico
-
Instituto do Cancer do Estado de São PauloUnknownCancer | Abdominal Surgery | Parenteral NutritionBrazil
-
Göteborg UniversityCompleted
-
University of ManchesterShire International GmbHCompleted
-
London North West Healthcare NHS TrustSt Mark's Hospital FoundationUnknownEnterocutaneous FistulaeUnited Kingdom
-
Lawson Health Research InstituteUnknownMalignant Hematologic NeoplasmCanada
-
Institut für Klinische Krebsforschung IKF GmbH...Terminated
-
Hebei Yanda Ludaopei HospitalNot yet recruitingNutrition Aspect of Cancer | Stem Cell Transplant Complications
-
University Hospital, LilleMinistry of Health, FranceTerminatedGastrointestinal Fistula | Enteral Nutritional SupportFrance
-
University Hospital, GenevaCompleted